83 related articles for article (PubMed ID: 35476179)
21. Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center.
Kanokwongnuwat W; Larbcharoensub N; Sriphrapradang C; Suppasilp C; Thamnirat K; Sakulpisuti C; Kositwattanarerk A; Utamakul C; Sritara C; Chamroonrat W
Endocrine; 2022 Jun; 77(1):134-142. PubMed ID: 35476179
[TBL] [Abstract][Full Text] [Related]
22. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.
Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG
Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004
[TBL] [Abstract][Full Text] [Related]
23. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
[TBL] [Abstract][Full Text] [Related]
24. Papillary thyroid microcarcinoma: an over-treated malignancy?
Wang TS; Goffredo P; Sosa JA; Roman SA
World J Surg; 2014 Sep; 38(9):2297-303. PubMed ID: 24791670
[TBL] [Abstract][Full Text] [Related]
25. Is papillary thyroid microcarcinoma an indolent tumor?: A retrospective study on 280 cases treated with radioiodine.
Gao X; Zhang X; Zhang Y; Hua W; Maimaiti Y; Gao Z
Medicine (Baltimore); 2016 Oct; 95(40):e5067. PubMed ID: 27749574
[TBL] [Abstract][Full Text] [Related]
26. Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy.
Nishihara E; Ito Y; Kudo T; Ito M; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
Endocr J; 2021 Jun; 68(6):649-654. PubMed ID: 33551434
[TBL] [Abstract][Full Text] [Related]
27. Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.
Leboulleux S; Bournaud C; Chougnet CN; Zerdoud S; Al Ghuzlan A; Catargi B; Do Cao C; Kelly A; Barge ML; Lacroix L; Dygai I; Vera P; Rusu D; Schneegans O; Benisvy D; Klein M; Roux J; Eberle MC; Bastie D; Nascimento C; Giraudet AL; Le Moullec N; Bardet S; Drui D; Roudaut N; Godbert Y; Morel O; Drutel A; Lamartina L; Schvartz C; Velayoudom FL; Schlumberger MJ; Leenhardt L; Borget I
N Engl J Med; 2022 Mar; 386(10):923-932. PubMed ID: 35263518
[TBL] [Abstract][Full Text] [Related]
28. Recurrence Factors and Characteristic Trends of Papillary Thyroid Cancer over Three Decades.
Chatchomchuan W; Thewjitcharoen Y; Karndumri K; Porramatikul S; Krittiyawong S; Wanothayaroj E; Vongterapak S; Butadej S; Veerasomboonsin V; Kanchanapitak A; Rajatanavin R; Himathongkam T
Int J Endocrinol; 2021; 2021():9989757. PubMed ID: 34054949
[TBL] [Abstract][Full Text] [Related]
29. Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?
Wu Z; Han L; Li W; Wang W; Chen L; Yao Y; Wang Y
Cancer Med; 2021 Mar; 10(5):1614-1622. PubMed ID: 33512778
[TBL] [Abstract][Full Text] [Related]
30. An impact of microscopic positive margin on incomplete response after I-131 treatment in differentiated thyroid cancer.
Raruenrom Y; Sawangsri K; Somboonporn C; Theerakulpisut D; Wongsurawat N; Ratanaanekchai T
Ann Nucl Med; 2020 Jul; 34(7):453-459. PubMed ID: 32323257
[TBL] [Abstract][Full Text] [Related]
31. Does the ATA Risk Stratification Apply to Patients with Papillary Thyroid Microcarcinoma?
Stefanova DI; Bose A; Ullmann TM; Limberg JN; Finnerty BM; Zarnegar R; Fahey TJ; Beninato T
World J Surg; 2020 Feb; 44(2):452-460. PubMed ID: 31605172
[TBL] [Abstract][Full Text] [Related]
32. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Filetti S; Durante C; Hartl D; Leboulleux S; Locati LD; Newbold K; Papotti MG; Berruti A;
Ann Oncol; 2019 Dec; 30(12):1856-1883. PubMed ID: 31549998
[No Abstract] [Full Text] [Related]
33. Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.
Cho SJ; Suh CH; Baek JH; Chung SR; Choi YJ; Chung KW; Shong YK; Lee JH
Thyroid; 2019 Oct; 29(10):1399-1408. PubMed ID: 31368412
[No Abstract] [Full Text] [Related]
34. Radioiodine remnant ablation in papillary thyroid microcarcinoma: a meta-analysis.
Yang T; Zheng SY; Jiao J; Zou Q; Zhang Y
Nucl Med Commun; 2019 Jul; 40(7):711-719. PubMed ID: 31095043
[TBL] [Abstract][Full Text] [Related]
35. Treatment efficacy between total thyroidectomy and lobectomy for patients with papillary thyroid microcarcinoma: A systemic review and meta-analysis.
Zheng W; Li J; Lv P; Chen Z; Fan P
Eur J Surg Oncol; 2018 Nov; 44(11):1679-1684. PubMed ID: 30158063
[TBL] [Abstract][Full Text] [Related]
36. Dynamic risk stratification in the follow-up of thyroid cancer: what is still to be discovered in 2017?
Krajewska J; Chmielik E; Jarząb B
Endocr Relat Cancer; 2017 Nov; 24(11):R387-R402. PubMed ID: 28821573
[TBL] [Abstract][Full Text] [Related]
37. Insights into the Management of Papillary Microcarcinoma of the Thyroid.
Miyauchi A; Ito Y; Oda H
Thyroid; 2018 Jan; 28(1):23-31. PubMed ID: 28629253
[TBL] [Abstract][Full Text] [Related]
38. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Lim H; Devesa SS; Sosa JA; Check D; Kitahara CM
JAMA; 2017 Apr; 317(13):1338-1348. PubMed ID: 28362912
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of ultrasonographic features for lymph node metastasis in papillary thyroid microcarcinoma: a single-center retrospective study.
Liu Z; Zeng W; Liu C; Wang S; Xiong Y; Guo Y; Li X; Sun S; Chen T; Maimaiti Y; Yu P; Huang T
World J Surg Oncol; 2017 Jan; 15(1):32. PubMed ID: 28125992
[TBL] [Abstract][Full Text] [Related]
40. A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.
Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Song DE; Sung TY; Yoon JH; Hong SJ; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2017 Apr; 176(4):371-378. PubMed ID: 28089996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
